Chen, Po-YuPo-YuChenCHIN-KUO CHANGChen, Chun-HsinChun-HsinChenFang, Su-ChenSu-ChenFangMondelli, ValeriaValeriaMondelliChiu, Chih-ChiangChih-ChiangChiuLu, Mong-LiangMong-LiangLuHwang, Ling-LingLing-LingHwangHuang, Ming-ChyiMing-ChyiHuang2022-04-292022-04-292022-04-060929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/609123Orexin-A levels are reportedly increased in antipsychotic (APD)-treated patients with schizophrenia compared to healthy controls and have been associated with metabolic abnormalities. It is not clear whether the orexin-A elevation is related specifically to the drug (APDs) effect, which should be clarified by including a drug-free group for comparison, or related to drug-induced metabolic abnormalities.enAntipsychotics; Metabolic syndrome; Orexin-A; Schizophrenia; Type 2 diabetes mellitus[SDGs]SDG3journal article10.1016/j.jfma.2022.03.008353961562-s2.0-85127715782https://api.elsevier.com/content/abstract/scopus_id/85127715782